Goldman Sachs Group Inc Fulgent Genetics, Inc. Transaction History
Goldman Sachs Group Inc
- $706 Billion
- Q2 2025
A detailed history of Goldman Sachs Group Inc transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 116,534 shares of FLGT stock, worth $2.45 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
116,534
Previous 202,820
42.54%
Holding current value
$2.45 Million
Previous $3.43 Million
32.42%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding FLGT
# of Institutions
188Shares Held
18.4MCall Options Held
185KPut Options Held
24.8K-
Black Rock Inc. New York, NY3.92MShares$82.4 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.44MShares$30.3 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.17MShares$24.5 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.13MShares$23.8 Million0.01% of portfolio
-
Acadian Asset Management LLC Boston, MA1.12MShares$23.5 Million0.05% of portfolio
About Fulgent Genetics, Inc.
- Ticker FLGT
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 30,265,800
- Market Cap $636M
- Description
- Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...